Drug-resistant tuberculosis

Oral Presentation
Chairs: R. Duarte (Porto, Portugal), S. Tiberi (London, United Kingdom)
High-dose rifampicin in tuberculosis: experiences from a Dutch tuberculosis centre
C. Seijger (Nijmegen, Netherlands), W. Hoefsloot (Nijmegen, Netherlands), I. Bergsma (Nijmegen, Netherlands), J. Van Ingen (Nijmegen, Netherlands), S. Kuijpers (Nijmegen, Netherlands), L. Te Brake (Nijmegen, Netherlands), R. Van Crevel (Nijmegen, Netherlands), R. Aarnoutse (Nijmegen, Netherlands), M. Boeree (Nijmegen, Netherlands), C. Magis-Escurra (Nijmegen, Netherlands)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Comorbidity clusters associated with length of hospital stay in patients with tuberculosis
F. Baty (St. Gallen, Switzerland), O. Schoch (St. Gallen, Switzerland), S. Tonko (St. Gallen, Switzerland), M. Brutsche (St. Gallen, Switzerland)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Results of traditional and new regimens of MDR/XDR TB treatment: cohort analysis
S. Borisov (Moscow, Russian Federation), A. Filippov (Moscow, Russian Federation), I. Danilova (Moscow, Russian Federation), S. Kosenkov (Moscow, Russian Federation)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Drug resistance-conferring mutations in Mycobacterium-tuberculosis isolated from retreated patients in Hanoi, Vietnam
N. Thi Le Hang (Hanoi, Vietnam), M. Hijikata (Tokyo, Japan), S. Maeda (Hokkaido, Japan), P. Huu Thuong (Hanoi, Vietnam), H. Van Huan (Hanoi, Vietnam), N. Phuong Hoang (Hanoi, Vietnam), I. Matsushita (Tokyo, Japan), N. Keicho (Tokyo, Japan)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study.
A. Skrahina (Minsk, Belarus), H. Hurevich (Minsk, Belarus), S. Setkina (Minsk, Belarus), V. Grankov (Minsk, Belarus), V. Solodovnikova (Minsk, Belarus), D. Viatushka (Minsk, Belarus), V. Kralko (Minsk, Belarus), D. Klimuk (Minsk, Belarus), M. Dara (Copenhagen, Denmark)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan
A. Takaki (Tokyo, Japan), A. Aono (Tokyo, Japan), K. Chikamatsu (Tokyo, Japan), Y. Igarashi (Tokyo, Japan), Y. Shimomura (Tokyo, Japan), Y. Murase (Tokyo, Japan), H. Yoshida (Osaka, Japan), . Tamura (Osaka, Japan), T. Nagai (Osaka, Japan), Y. Morishige (Tokyo, Japan), H. Yamada (Tokyo, Japan), S. Mitarai (Tokyo, Japan)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Tobacco smoking as a risk factor of active tuberculosis in HIV-infected patients
E. Kulabukhova (Moscow, Russian Federation), V. Zimina (Moscow, Russian Federation), A. Kravtchenko (Moscow, Russian Federation), S. Degtyareva (Moscow, Russian Federation), E. Beloborodova (Moscow, Russian Federation), A. Peregudova (Moscow, Russian Federation)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster